Quantum-Si
QSI
, develops access to the proteome with single-molecule analysis and democratizing to researchers & clinicians
Also, "is the world’s first-to-market provider of protein sequencing instruments with core technology based on proprietary time-domain sequencing that enables resolution of amino acids during experiments".- Ark Invest
The stock is near finalizing its bottoming process with a pivot buy at $2.50
The Biotech ETF
XBI
already broke out so
QSI
is no leader, but still is a good set up.
QSI
, develops access to the proteome with single-molecule analysis and democratizing to researchers & clinicians Also, "is the world’s first-to-market provider of protein sequencing instruments with core technology based on proprietary time-domain sequencing that enables resolution of amino acids during experiments".- Ark Invest
The stock is near finalizing its bottoming process with a pivot buy at $2.50
The Biotech ETF
XBI
already broke out so
QSI
is no leader, but still is a good set up.